Syndax Pharmaceuticals, Inc. (SNDX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SNDX Syndax Pharmaceuticals, Inc.

盘后交易 04-25 18:08:35 EDT

20.57

-0.22

-1.06%

盘后20.57

+0.000.00%

16:20 EDT

最高20.80	最低20.13	成交量58.90万
今开20.43	昨收20.79	日振幅3.22%
总市值17.48亿	流通市值17.41亿	总股本8,498万
成交额1,211万	换手率0.70%	流通股本8,464万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SNDX","market":"US","secType":"STK","nameCN":"Syndax Pharmaceuticals, Inc. ","latestPrice":20.57,"timestamp":1714075200000,"preClose":20.79,"halted":0,"volume":588963,"hourTrading":{"tag":"盘后","latestPrice":20.57,"preClose":20.57,"latestTime":"16:20 EDT","volume":31184,"amount":641454.88,"timestamp":1714076400885},"delay":0,"floatShares":84639673,"shares":84979686,"eps":-2.98,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.22,"latestTime":"04-25 18:08:35 EDT","open":20.43,"high":20.8,"low":20.13,"amount":12112424.58984,"amplitude":0.032227,"askPrice":23.82,"askSize":100,"bidPrice":20.05,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.98,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714089600000},"adr":0,"listingDate":1456981200000,"adjPreClose":20.79,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":20.57,"preClose":20.57,"latestTime":"16:20 EDT","volume":31184,"amount":641454.88,"timestamp":1714076400885},"volumeRatio":0.723373},"requestUrl":"/m/hq/s/SNDX","defaultTab":"news","newsList":[{"id":"2426410129","title":"Syndax Pharmaceuticals, Inc.盘中异动 大幅跳水5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426410129","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426410129?lang=zh_cn&edition=full","pubTime":"2024-04-11 00:30","pubTimestamp":1712766644,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日00时30分，Syndax Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.09%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.25%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Orgenesis Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1915.38%、76.53%、51.56%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Orgenesis Inc.、Nutriband Inc C/Wts ，振幅分别为87.61%、74.23%、52.44%。Syndax Pharmaceuticals, Inc.公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110030447a51ed0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110030447a51ed0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420798966","title":"美国研究综述-迪克体育用品、Nvidia、PVH","url":"https://stock-news.laohu8.com/highlight/detail?id=2420798966","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420798966?lang=zh_cn&edition=full","pubTime":"2024-03-20 15:14","pubTimestamp":1710918896,"startTime":"0","endTime":"0","summary":"    路透社3月20日 - 华尔街证券分析师周三调整了对迪克体育用品公司、英伟达和 PVH 等几家美国上市公司的评级和目标价。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2416964990","title":"Syndax Pharmaceuticals, Inc.2023财年实现净利润-2.09亿美元，同比减少40.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416964990","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2416964990?lang=zh_cn&edition=full","pubTime":"2024-03-03 00:27","pubTimestamp":1709396833,"startTime":"0","endTime":"0","summary":"12月31日，Syndax Pharmaceuticals, Inc.公布财报，公告显示公司2023财年净利润为-2.09亿美元，同比减少40.27%；其中营业收入为0.00美元，每股基本收益为-2.98美元。机构评级：截至2023年12月31日，当前有11家机构对Syndax Pharmaceuticals, Inc.目标价做出预测，其中目标均价为35.27美元，其中最低目标价为23.00美元，最高目标价为45.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300271687dcef3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030300271687dcef3b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2392918644","title":"Syndax Pharmaceuticals Inc盘中异动 下午盘股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2392918644","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2392918644?lang=zh_cn&edition=full","pubTime":"2023-12-19 02:01","pubTimestamp":1702922476,"startTime":"0","endTime":"0","summary":"北京时间2023年12月19日02时01分，Syndax Pharmaceuticals Inc股票出现波动，股价大幅跳水5.06%。Syndax Pharmaceuticals Inc股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Invivyd Inc、Panbela Therapeutics Inc、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Panbela Therapeutics Inc、Zyversa Therapeutics Inc、Invivyd Inc较为活跃，换手率分别为1711.24%、59.14%、48.11%，振幅较大的相关个股有Panbela Therapeutics Inc、Invivyd Inc、Celularity Inc C/Wts 16/07/2026 ，振幅分别为168.10%、165.03%、111.11%。Syndax Pharmaceuticals Inc公司简介：Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司，致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231219020117806b3b01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231219020117806b3b01&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.syndax.com","stockEarnings":[{"period":"1week","weight":0.0024},{"period":"1month","weight":-0.0735},{"period":"3month","weight":0.0474},{"period":"6month","weight":0.6916},{"period":"1year","weight":-0.0152},{"period":"ytd","weight":-0.0379}],"compareEarnings":[{"period":"1week","weight":0.0097},{"period":"1month","weight":-0.0276},{"period":"3month","weight":0.0356},{"period":"6month","weight":0.2307},{"period":"1year","weight":0.2446},{"period":"ytd","weight":0.0633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Syndax Pharmaceuticals, Inc.于2005年10月11日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，正在开发癌症疗法的创新管道。该公司正在开发revumenib，这是一种有效的、选择性的、menin-MLL结合相互作用的小分子抑制剂，用于治疗KMT2A重排或KMT2AR，也称为混合谱系白血病重排或MLLR，包括急性淋巴细胞白血病或ALL在内的急性白血病，以及急性髓细胞白血病或AML，以及necleophosmin 1，也称为NPM1，突变AML。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.044305},{"month":2,"riseRate":0.625,"avgChangeRate":0.07889},{"month":3,"riseRate":0.625,"avgChangeRate":0.084467},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.0022},{"month":5,"riseRate":0.5,"avgChangeRate":0.018525},{"month":6,"riseRate":0.5,"avgChangeRate":0.001339},{"month":7,"riseRate":0.5,"avgChangeRate":-0.000294},{"month":8,"riseRate":0.625,"avgChangeRate":0.063716},{"month":9,"riseRate":0.625,"avgChangeRate":-0.024123},{"month":10,"riseRate":0.25,"avgChangeRate":-0.081003},{"month":11,"riseRate":0.625,"avgChangeRate":0.015744},{"month":12,"riseRate":0.5,"avgChangeRate":0.063584}],"exchange":"NASDAQ","name":"Syndax Pharmaceuticals, Inc. ","nameEN":"Syndax Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Syndax Pharmaceuticals, Inc. (SNDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Syndax Pharmaceuticals, Inc. (SNDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Syndax Pharmaceuticals, Inc. ,SNDX,Syndax Pharmaceuticals, Inc. 股票,Syndax Pharmaceuticals, Inc. 股票老虎,Syndax Pharmaceuticals, Inc. 股票老虎国际,Syndax Pharmaceuticals, Inc. 行情,Syndax Pharmaceuticals, Inc. 股票行情,Syndax Pharmaceuticals, Inc. 股价,Syndax Pharmaceuticals, Inc. 股市,Syndax Pharmaceuticals, Inc. 股票价格,Syndax Pharmaceuticals, Inc. 股票交易,Syndax Pharmaceuticals, Inc. 股票购买,Syndax Pharmaceuticals, Inc. 股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Syndax Pharmaceuticals, Inc. (SNDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Syndax Pharmaceuticals, Inc. (SNDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}